The frequency and management of breakthrough bleeding during extended therapy with the transvaginal contraceptive ring.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2010
At a glance
- Drugs Ethinylestradiol/etonogestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 01 Sep 2008 Primary endpoint 'Menstrual bleeding' has been met.
- 01 Sep 2008 Results reported in Obstetrics and Gynecology.
- 21 Jul 2007 New trial record.